Design of Multi-Epitope Vaccine against SARS-CoV-2

1. Tan, H. W., Y. M. Xu, A. Lau. Angiotensin-Converting Enzyme 2: The Old Door for New Severe Acute Respiratory Syndrome Coronavirus 2 Infection. – Reviews in Medical Virology, 2020, e2122.10.1002/rmv.2122736119832602627Search in Google Scholar

2. Tai, W., L. He, X. Zhang, J. Pu, D. Voronin, S. Jiang, Y. Zhou, L. Du. Characterization of the Receptor-Binding Domain (RBD) of 2019 Novel Coronavirus: Implication for Development of RBD Protein as a Viral Attachment Inhibitor and Vaccine. – Cellular & Molecular Immunology, Vol. 17, 2020, Issue 6, pp. 613-620.10.1038/s41423-020-0400-4709188832203189Search in Google Scholar

3. Chen, B., E. K. Tian, B. He, L. Tian, R. Han, S. Wang, Q. Xiang, S. Zhang, T. ElArnaout, W. Cheng. Overview of Lethal Human Coronaviruses. – Signal Transduction and Targeted Therapy, Vol. 5, 2020, Issue 1, 89.10.1038/s41392-020-0190-2728971532533062Search in Google Scholar

4. Walls, A. C., Y. J. Park, M. A. Tortorici, A. Wall, A. T. McGuire, D. Veesler. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. – Cell, Vol. 181, 2020, Issue 2, pp. 281-292.10.1016/j.cell.2020.02.058710259932155444Search in Google Scholar

5. Surya, W., Y. Li, J. Torres. Structural Model of the SARS Coronavirus E Channel in LMPG Micelles. – Biochimica et Biophysica Acta. Biomembranes, Vol. 1860, 2018, Issue 6, pp. 1309-1317.Search in Google Scholar

6. Wrapp, D., N. Wang, K. S. Corbett, J. A. Goldsmith, C. Hsieh, O. Abiona, B. S. Graham, J. S. McLellan. Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. – Science, Vol. 367, 2020, Issue 6483, pp. 1260-1263.10.1126/science.abb2507716463732075877Search in Google Scholar

7. Li, F. Structure, Function, and Evolution of Coronavirus Spike Proteins. – Annual Review of Virology, Vol. 3, 2016, Issue 1, pp. 237-261.10.1146/annurev-virology-110615-042301545796227578435Search in Google Scholar

8. Nieto-Torres, J. L., M. L. DeDiego, C. Verdiá-Báguenaetal. Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis – PLoS Pathogens, Vol. 10, 2014, Issue 5, e1004077.10.1371/journal.ppat.1004077400687724788150Search in Google Scholar

9. DeDiego, M. L., E. Alvarez, F. Almazán, M. T. Rejas, E. Lamirande, A. Roberts, W. J. Shieh, S. R. Zaki, K. Subbarao, L. Enjuanes. A Severe Acute Respiratory Syndrome Coronavirus that Lacks the E Gene is Attenuated in Vitro and in Vivo. – Journal of Virology, Vol. 81, 2007, Issue 4, pp. 1701-1713.10.1128/JVI.01467-06179755817108030Search in Google Scholar

10. Corse, E., C. E. Machamer. Infectious Bronchitis Virus E Protein is Targeted to the Golgi Complex and Directs Release of Virus-Like Particles. – Journal of Virology, Vol. 74, 2000, Issue 9, pp. 4319-4326.10.1128/JVI.74.9.4319-4326.200011194910756047Search in Google Scholar

11. Liu, J., Y. Sun, J. Qi, F. Chu, H. Wu, F. Gao, T. Li, J. Yan, G. F. Gao. The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Acts as a Dominant Immunogen Revealed by a Clustering Region of Novel Functionally and Structurally Defined Cytotoxic T-Lymphocyte Epitopes. – The Journal of Infectious Diseases, Vol. 202, 2010, Issue 8, pp. 1171-1180.10.1086/656315753748920831383Search in Google Scholar

12. Surjit, M., S. K. Lal. The SARS-CoV Nucleocapsid Protein: A Protein with Multifarious Activities. – Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, Vol. 8, 2008, Issue 4, pp. 397-405.Search in Google Scholar

13. Yan, X., Q. Hao, Y. Mu, K. A. Timani, L. Ye, Y. Zhu, J. W u. Nucleocapsid Protein of SARS-CoV Activates the Expression of Cyclooxygenase-2 by Binding Directly to Regulatory Elements for Nuclear Factor-Kappa B and CCAAT/Enhancer Binding Protein. – The International Journal of Biochemistry & Cell Biology, Vol. 38, 2006, Issue 8, pp. 1417-1428.10.1016/j.biocel.2006.02.003710841516546436Search in Google Scholar

14. Patronov, A., I. Doytchinova. T-Cell Epitope Vaccine Design by Immunoinformatics. – Open Biology, Vol. 3, 2013, Issue 1. DOI: 10.1098/rsb. 120139.Search in Google Scholar

15. Yang, L. T., H. Peng, Z. L. Zhu, G. Li, Z. T. Huang, Z. X. Zhao, R. A. Koup, R. T. Bailer, C. Y. Wu. Long-Lived Effector/Central Memory T-Cell Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) S Antigen in Recovered SARS Patients. – Clinical Immunology (Orlando, Florida), Vol. 120, 2006, Issue 2, pp. 171-178.10.1016/j.clim.2006.05.002710613216781892Search in Google Scholar

16. Lucas, M., U. Karrer, A. Lucas, P. Klenerman. Viral Escape Mechanisms – Escapology Taught by Viruses. – International Journal of Experimental Pathology, Vol. 82, 2001, Issue 5, pp. 269-286.10.1046/j.1365-2613.2001.00204.x251778011703537Search in Google Scholar

17. Hajeer, A. H., H. Balkhy, S. Johani, M. Z. Yousef, Y. Arabi. Association of Human Leukocyte Antigen Class II Alleles with Severe Middle East Respiratory Syndrome-Coronavirus Infection. – Annals of Thoracic Medicine, Vol. 11, 2016, Issue 3, pp. 211-213.10.4103/1817-1737.185756496622427512511Search in Google Scholar

18. Tay, M. Z., C. M. Poh, L. Rénia, P. A. MacAry, L. Ng. The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nature Reviews. – Immunology, Vol. 20, 2020, Issue 6, pp. 363-374.10.1038/s41577-020-0311-8718767232346093Search in Google Scholar

19. Robinson, J., D. J. Barker, X. Georgiou, M. A. Cooper, P. Flicek, S. G. E. Marsh. IPD-IMGT/HLA Database. – Nucleic Acids Research, Vol. 48, 2020, Database Issue, pp. D948-D955.10.1093/nar/gkz950714564031667505Search in Google Scholar

20. Blackwell, J. M., S. E. Jamieson, D. Burgner. HLA and Infectious Diseases. – Clinical Microbiology Reviews, Vol. 22, 2009, Issue 2, pp. 370-385.10.1128/CMR.00048-08266822819366919Search in Google Scholar

21. Ng, M. H., S. H. Cheng, K. M. Lau, G. M. Leung, U. S. Khoo, B. C. Zee, J. J. Sung. Immunogenetics in SARS: A Case-Control Study. – Hong Kong Medical Journal, Vol. 16, 2010, Issue 5 (Suppl. 4), pp. 29-33.Search in Google Scholar

22. Ng, M. H., K. M. Lau, L. Li, S. H. Cheng, W. Y. Chan, P. K. Hui, B. Zee, C. B. Leung, J. J. Sung. Association of Human-Leukocyte-Antigen Class I (B*0703) and Class II (DRB1*0301) Genotypes with Susceptibility and Resistance to the Development of Severe Acute Respiratory Syndrome. – The Journal of Infectious Diseases, Vol. 190, 2004, Issue 3, pp. 515-518.10.1086/421523710964615243926Search in Google Scholar

23. Yuan, F. F., Z. Velickovic, L. J. Ashton, W. B. Dyer, A. F. Geczy, H. Dunckley, G. W. Lynch, J. S. Sullivan. Influence of HLA Gene Polymorphisms on Susceptibility and Outcome Post Infection with the SARS-CoV Virus. – Virologica Sinica, Vol. 29, 2014, Issue 2, pp. 128-130.10.1007/s12250-014-3398-x709067024643938Search in Google Scholar

24. ThanhLe, T., Z. Andreadakis, A. Kumar, R. GómezRomán, S. Tollefsen, M. Saville, S. Mayhew. The COVID-19 Vaccine Development Landscape. – Nature Reviews. Drug Discovery, Vol. 19, 2020, Issue 5, pp. 305-306.10.1038/d41573-020-00073-532273591Search in Google Scholar

25. Benson, D. A., M. Cavanaugh, K. Clark, I. Karsch-Mizrachi, D. J. Lipman, J. Ostell, E. W. Sayers. GenBank. – Nucleic Acids Research, Vol. 41, 2013, Database Issue, pp. D36-D42.10.1093/nar/gks1195353119023193287Search in Google Scholar

26. Doytchinova, I. A., P. Guan, D. R. Flower. EpiJen: A Server for Multi-Step T Cell Epitope Prediction. – BMC Bioinformatics, Vol. 7, 2006, 131.10.1186/1471-2105-7-131142144316533401Search in Google Scholar

27. Doytchinova, I. A., D. R. Flower. Class I T Cell Epitope Prediction: Improvements Using a Combination of Proteasome Cleavage, TAP Affinity, and MHC Binding. – Molecular Immunology, Vol. 43, 2006, Issue 13, pp. 2037-2044.10.1016/j.molimm.2005.12.01316524630Search in Google Scholar

28. Doytchinova, I. A., S. Hemsley, D. R. Flower. Transporter Associated with Antigen Processing Preselection of Peptides Binding to the MHC: A Bioinformatic Evaluation. – Journal of Immunology, Vol. 173, 2004, Issue 11, pp. 6813-6819.10.4049/jimmunol.173.11.681315557175Search in Google Scholar

29. Lapinsh, M., P. Prusis, A. Gutcaits, T. Lundstedt, J. E. Wikberg. Development of Proteo-Chemometrics: A Novel Technology for the Analysis of Drug-Receptor Interactions. – Biochimica et Biophysica Acta, Vol. 1525, 2001, Issue 1-2, pp. 180-190.Search in Google Scholar

30. Dimitrov, I., P. Garnev, D. R. Flower, I. Doytchinova. EpiTOP – A Proteochemometric Tool for MHC Class II Binding Prediction. – Bioinformatics, Vol. 26, 2010, Issue 16, pp. 2066-2068.10.1093/bioinformatics/btq32420576624Search in Google Scholar

31. Atanasova, M., A. Patronov, I. Dimitrov, D. R. Flower, I. Doytchinova. EpiDOCK – A Molecular Docking-Based Tool for MHC Class II Binding Prediction. – Protein Engineering Design and Selection, Vol. 26, 2013, Issue 10, pp. 631-634.10.1093/protein/gzt01823661105Search in Google Scholar

32. Speiser, D. E., M. F. Bachmann. COVID-19: Mechanisms of Vaccination and Immunity. – Vaccines, Vol. 8, 2020, Issue 3, E404.10.3390/vaccines8030404756447232707833Search in Google Scholar

33. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-nCoV and Naming it SARS-CoV-2. – Nature Microbiology, Vol. 5, 2020, Issue 4, pp. 536-544.10.1038/s41564-020-0695-z709544832123347Search in Google Scholar